Skip to content

Milrinone on Right Ventricular Strain in Cardiac Surgery

Effect of Milrinone on the Right Ventricular Strain in Cardiac Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06077721
Enrollment
41
Registered
2023-10-11
Start date
2023-11-03
Completion date
2024-12-31
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease, Valvular Heart Disease

Keywords

Milrinone, strain, systolic function

Brief summary

The purpose of this study is to analyze the changes in right ventricular strain before and after milrinone administration in order to find out whether milrinone improves RV systolic performance in patients undergoing cardiac surgery.

Interventions

DRUGMilrinone

giving intravenous milrinone: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/ min infusion

Sponsors

Konkuk University Medical Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient agree and provide written informed consent. * patient undergoing elective cardiac surgery * preoperative LV EF\>50% (TTE)

Exclusion criteria

* preoperative cardiac dysrhythmia * preoperative IABP * use of other inotropic agents

Design outcomes

Primary

MeasureTime frame
1. Right ventricular strain15 min after milrinone administration

Secondary

MeasureTime frame
Left ventricular strain15 min after milrinone administration
Left ventricular ejection fraction15 min after milrinone administration

Countries

South Korea

Contacts

Primary ContactTae-Yop Kim, MD PhD
taeyop@gmail.com82-2-2030-5457

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026